Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT-141 crossover study of social communication in healthy adults
ACTRN12615001033538Phase 2Completed
- Sponsor
- University of Sydney
- Start
- Oct 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of bremelanotide (2 arms), sponsored by University of Sydney. Primary endpoints: Correct recognition performance in reading emotions from faces and Amount of eye gaze to the eyes of faces. Started Oct 2015; status: completed.
02
Drugs
bremelanotide
Beyond the preview
Go deeper on ACTRN12615001033538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001033538.